Keywords: head-to-head, avonex, rebif, trial, ms, initiated, ares-serono

Head-to-head Avonex, Rebif trial in MS initiated

Article | 11 October 1999

Ares-Serono has started a head-to-head trial to compare theefficacy and safety of a high dose of its interferon beta-1a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in